Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity - PubMed (original) (raw)

Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity

Sofiya Milman et al. Aging Cell. 2014 Aug.

Abstract

Attenuated growth hormone and insulin-like growth factor-1 (GH/IGF-1) signaling is associated with extended lifespan in several animal models. However, the effect of diminished GH/IGF-1 activity on survival in humans has not been confirmed. We tested the hypothesis that IGF-1 levels in nonagenarians (n = 184), measured at study enrollment, predict the duration of their incremental survival. In the Kaplan-Meier analysis, females with IGF-1 levels below the median (≤ 96 ng mL(-1) ) had significantly longer survival compared with females with levels above the median, P < 0.01. However, this survival advantage was not observed in males (P = 0.83). On the other hand, in both males and females with a history of cancer, lower IGF-1 levels predicted longer survival (P < 0.01). IGF-1 level remained a significant predictor of survival duration in linear regression models after multivariable adjustment in females (P = 0.01) and individuals with a history of cancer (P < 0.01). We show for the first time that low IGF-1 levels predict life expectancy in exceptionally long-lived individuals.

Keywords: IGF-1; cancer; human; insulin-like growth factor 1; longevity; mortality.

© 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Kaplan–Meier curves for groups with IGF-1 levels below (low IGF-1) and above (high IGF-1) the median (A–D). _P_-values for comparison between IGF-1 groups. (A) Females, P < 0.01. (B) Males, P = 0.83. (C) Negative history of malignancy, P = 0.42. (D) Positive history of malignancy, P < 0.01.

Similar articles

Cited by

References

    1. Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J. Gerontol. A Biol. Sci. Med. Sci. 2012;67:395–405. - PMC - PubMed
    1. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384:33. - PubMed
    1. CDC/NCHS, National Vital Statistics System. 2010. http://www.cdc.gov/nchs/data/hus/hus10.pdf [accessed on 10 October 2013]
    1. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P, Longo VD. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 2011;3:70ra13. - PMC - PubMed
    1. Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J. Gerontol. A Biol. Sci. Med. Sci. 2003;58:291–296. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources